These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 11721429)
1. [Expression and role of cyclin D3 in childhood acute leukemia]. Zhang L; Li J Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):347-9. PubMed ID: 11721429 [TBL] [Abstract][Full Text] [Related]
2. Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma. Sasaki E; Yatabe Y; Hashimoto M; Yamashita Y; Hasegawa Y; Kojima H; Nagasawa T; Mori N Pathol Int; 2007 Feb; 57(2):53-9. PubMed ID: 17300668 [TBL] [Abstract][Full Text] [Related]
3. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy. Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124 [TBL] [Abstract][Full Text] [Related]
4. Deregulation of cyclin D2 by juxtaposition with T-cell receptor alpha/delta locus in t(12;14)(p13;q11)-positive childhood T-cell acute lymphoblastic leukemia. Karrman K; Andersson A; Björgvinsdóttir H; Strömbeck B; Lassen C; Olofsson T; Nguyen-Khac F; Berger R; Bernard O; Fioretos T; Johansson B Eur J Haematol; 2006 Jul; 77(1):27-34. PubMed ID: 16548914 [TBL] [Abstract][Full Text] [Related]
5. Expression of cyclin genes in human gastric cancer and in first degree relatives. Yu J; Miehlke S; Ebert MP; Szokodi D; Wehvnignh B; Malfertheiner P; Ehninger G; Bayerdoerffer E Chin Med J (Engl); 2002 May; 115(5):710-5. PubMed ID: 12133540 [TBL] [Abstract][Full Text] [Related]
6. D cyclins in CD5+ B-cell lymphoproliferative disorders: cyclin D1 and cyclin D2 identify diagnostic groups and cyclin D1 correlates with ZAP-70 expression in chronic lymphocytic leukemia. Meyerson HJ; MacLennan G; Husel W; Cocco A; Tse W; Lazarus HM; Kaplan D Am J Clin Pathol; 2006 Feb; 125(2):241-50. PubMed ID: 16393687 [TBL] [Abstract][Full Text] [Related]
8. Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia. Sauerbrey A; Häfer R; Zintl F; Volm M Anticancer Res; 1999; 19(1B):645-9. PubMed ID: 10216470 [TBL] [Abstract][Full Text] [Related]
9. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms. Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653 [TBL] [Abstract][Full Text] [Related]
10. Cyclin alterations in giant cell tumor of bone. Kauzman A; Li SQ; Bradley G; Bell RS; Wunder JS; Kandel R Mod Pathol; 2003 Mar; 16(3):210-8. PubMed ID: 12640100 [TBL] [Abstract][Full Text] [Related]
11. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms. Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405 [TBL] [Abstract][Full Text] [Related]
12. Cyclin A1 expression and associations with disease characteristics in childhood acute lymphoblastic leukemia. Holm C; Ora I; Brunhoff C; Anagnostaki L; Landberg G; Persson JL Leuk Res; 2006 Mar; 30(3):254-61. PubMed ID: 16182364 [TBL] [Abstract][Full Text] [Related]
13. Expression of cyclins D1, D2, and D3 and Ki-67 in Leukemia. Jaroslav P; Martina H; Jirí S; Hana K; Petr S; Tomás K; Julius M; Cedrik H Leuk Lymphoma; 2005 Nov; 46(11):1605-1612. PubMed ID: 16334487 [TBL] [Abstract][Full Text] [Related]
14. [The clinical significance of cyclin B1 expression in adult acute leukemia patients]. Ma WD; Xu SR; Guo XN; Jia JS; Xue F Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):523-6. PubMed ID: 14690581 [TBL] [Abstract][Full Text] [Related]
15. G1-phase regulators, cyclin D1, cyclin D2, and cyclin D3: up-regulation at gastrulation and dynamic expression during neurulation. Wianny F; Real FX; Mummery CL; Van Rooijen M; Lahti J; Samarut J; Savatier P Dev Dyn; 1998 May; 212(1):49-62. PubMed ID: 9603423 [TBL] [Abstract][Full Text] [Related]
16. [Expression of cyclin D1 mRNA in acute leukemia patients and its clinical implication]. Li H; Wang Y; Lou F Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):357-8. PubMed ID: 11721432 [TBL] [Abstract][Full Text] [Related]
17. Deregulation of D-type cyclins in uterine cancers. Cyclin D1/D3 is differentially expressed in cervical cancer. Skomedal H; Forus A; Holm R Anticancer Res; 2003; 23(5A):3929-35. PubMed ID: 14666699 [TBL] [Abstract][Full Text] [Related]
18. Cyclins D1, D3, E, and A in vulvar carcinoma patients. Knopp S; Bjørge T; Nesland JM; Tropé C; Holm R Gynecol Oncol; 2005 Jun; 97(3):733-9. PubMed ID: 15894358 [TBL] [Abstract][Full Text] [Related]
19. The effect of cyclin D expression on cell proliferation in human gliomas. Zhang X; Zhao M; Huang AY; Fei Z; Zhang W; Wang XL J Clin Neurosci; 2005 Feb; 12(2):166-8. PubMed ID: 15749420 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1). Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]